English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/124313
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Effect of PARP Inhibitors on TRAIL-induced cell death in gliobastoma cell lines

AuthorsSerrano-Sáenz, Santiago; López-Rivas, Abelardo ; Oliver, Francisco Javier
Issue Date24-Sep-2014
CitationVII Reunión Anual de la Red Temática de Investigación Cooperativa en Cáncer (2014)
AbstractTRAIL (Tumor necrosis factor‐related apoptosis‐inducing ligand) has been proved to be an effective anti‐neoplastic agent in pre‐clinical trials. However, cells from Glioblastoma (GBM, most common and lethal brain tumor) are resistant to this therapy. Therefore, the research of new combined therapies which enhance the effect of TRAIL could probably offer an interesting alternative option. PARP1 has been shown to modify and inactivate DISC components impairing TRAIL‐induced cell death.
DescriptionPóster presentado en la VII Reunión Anual de la Red Temática de Investigación Cooperativa en Cáncer (RTICC), celebrada en Salamanca el 24 de septiembre de 2014
Appears in Collections:(CABIMER) Comunicaciones congresos
(IPBLN) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
Effect of PARP Inhibitors on TRAIL_SerranoSaenz.pdf686,85 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.